
Opinion|Videos|March 28, 2025
Utilizing Gene Expression Profiling to Avoid Unnecessary Interventions in a 72-Year-Old Woman With Melanoma
Author(s)David Cotter, MD, PhD
An expert discusses initial thoughts on the case, including the risk category the patient would fall into based on the characteristics of their lesion, outlines the treatment guidelines for melanoma based on their risk, and suggests the frequency of surveillance visits solely based on their traditional risk classification.
Advertisement
Episodes in this series

Video content above is prompted by the following:
- Discuss your initial thoughts on this case. What risk category would you place this patient in based on the characteristics of their lesion?
- What are the treatment guidelines for their risk of melanoma? How often would you suggest surveillance visits for this patient, based solely on their traditional risk classification?
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
FDA Grants Breakthrough Therapy Designation to Litifilimab for Cutaneous Lupus Erythematosus
2
Phase 2b Analysis Shows Consistent Vitiligo Repigmentation With Ritlecitinib
3
On the Horizon: Innovations in the Acne Treatment Pipeline
4
Dual ITK/JAK3 Inhibition Shows Strong Preclinical Activity in Severe Alopecia Areata
5








